Literature DB >> 12409886

White-coat effect in normotension and hypertension.

Nikos A Zakopoulos1, Vasilios T Kotsis, Vassiliki Ch Pitiriga, Savvas T Toumanidis, John P Lekakis, Serafim N Nanas, Kostas N Vemmos, Stamatios F Stamatelopoulos, Spyridon D Moulopoulos.   

Abstract

OBJECTIVES: The difference between clinic and daytime ambulatory blood pressure is referred to as the white-coat effect. In this study, we investigated (i) the magnitude of the white-coat effect in subjects with different daytime ambulatory blood pressure levels, and (ii) the association of the white-coat effect with left ventricular mass.
METHODS: A total of 1581 subjects underwent clinic blood pressure readings, 24-h ambulatory blood pressure monitoring and left ventricular echocardiographic assessment. Their mean daytime systolic blood pressure varied from 88.0 to 208.9 mmHg and their mean daytime diastolic blood pressure from 40.3 to 133.0 mmHg.
RESULTS: A negative correlation was found between the systolic or diastolic white-coat effect and the systolic or diastolic daytime ambulatory blood pressure (r = -0.22, P < 0.000 and r = -0.50, P < 0.000, respectively). Left ventricular mass significantly correlated with ambulatory blood pressure (P < 0.001), but there was no association between left ventricular mass and clinic blood pressure or white-coat effect. Furthermore, the white-coat effect was reversed at the highest level of systolic or diastolic daytime ambulatory blood pressure (systolic over 170 mmHg or diastolic over 100 mmHg) when systolic or diastolic daytime ambulatory blood pressure was higher than systolic or diastolic clinic blood pressure (ambulatory blood pressure hypertension).
CONCLUSIONS: The white-coat effect shows an inverse association with daytime ambulatory blood pressure level (systolic or diastolic), being significantly more prominent for levels below 140/80 mmHg for systolic/diastolic daytime ambulatory blood pressure and reversed with daytime ambulatory blood pressure levels above 170/100 mmHg.

Entities:  

Mesh:

Year:  2002        PMID: 12409886     DOI: 10.1097/00126097-200210000-00004

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  7 in total

1.  Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension.

Authors:  Abdullah Shehab; Abdishakur Abdulle
Journal:  BMC Cardiovasc Disord       Date:  2011-01-11       Impact factor: 2.298

Review 2.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

3.  Prevalence and reproducibility of differences between home and ambulatory blood pressure and their relation with hypertensive organ damage.

Authors:  K Gazzola; M Cammenga; N V van der Hoeven; G A van Montfrans; B J H van den Born
Journal:  J Hum Hypertens       Date:  2017-04-06       Impact factor: 3.012

4.  Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension.

Authors:  William M Tierney; Margaret Brunt; Joseph Kesterson; Xiao-Hua Zhou; Gil L'Italien; Pablo Lapuerta
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

5.  Screening for hypertension annually compared with current practice.

Authors:  Gregory M Garrison; Sara Oberhelman
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

6.  The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension.

Authors:  Linda Beckett; Marshall Godwin
Journal:  BMC Cardiovasc Disord       Date:  2005-06-28       Impact factor: 2.298

Review 7.  The applicability of home blood pressure measurement in clinical practice: a review of literature.

Authors:  Willem J Verberk; Abraham A Kroon; Heidi A Jongen-Vancraybex; Peter W de Leeuw
Journal:  Vasc Health Risk Manag       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.